The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26572217 |
60 |
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors. |
Genentech |
25611347 |
2 |
Quinofuracins A-E, produced by the fungus Staphylotrichum boninense PF1444, show p53-dependent growth suppression. |
Institute of Microbial Chemistry (Bikaken) |
23726034 |
117 |
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. |
Novartis Institutes For Biomedical Research |
22524527 |
13 |
Structure-based design of novel inhibitors of the MDM2-p53 interaction. |
Amgen |
19856920 |
10 |
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction. |
Amgen |
30660827 |
70 |
Quinolone hybrids and their anti-cancer activities: An overview. |
Qilu University of Technology (Shandong Academy of Sciences) |
23075044 |
3 |
Small molecules that target protein misfolding. |
Pfizer |
30075999 |
11 |
Novel tertiary sulfonamides as potent anti-cancer agents. |
Human Biomolecular Research Institute |
29702446 |
25 |
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. |
University of Southampton |
28947947 |
112 |
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. |
Novartis Institutes For Biomedical Research |